V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10372286 | 10040240 | null | null | 03 | 2018-10-30 | 2018-11-01 | CYTARABINE | 02 | N | CISPLATIN + VINORELBINE | 100027068 |
| 10372296 | 10040241 | 1.66 | 81.8 | Adjuvant (A) | 2017-03-03 | 2017-03-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101588932 |
| 10372411 | 10040243 | 1.7 | 58.8 | Palliative (P) | 2019-03-29 | 2019-04-04 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101724871 |
| 10372447 | 10040245 | 1.82 | 85.1 | 03 | 2017-09-23 | 2017-10-06 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100321134 |
| 10372468 | 10040246 | 1.68 | 78.3 | Palliative (P) | 2018-09-26 | 2018-10-09 | CTD (Thalidomide 100mg) | 02 | N | BUSULFAN | 100511834 |
| 10372542 | 10040248 | 1.75 | 46.9 | null | 2018-03-02 | 2018-03-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101828484 |
| 10372614 | 10040251 | 1.68 | 0 | Palliative (P) | null | 2016-05-04 | Trial Unspecified | 02 | N | POMALIDOMIDE | 100242286 |
| 10372696 | 10040253 | 1.72 | 70 | Curative (C) | 2018-12-14 | 2018-12-14 | POMALIDOMIDE | 02 | Y | CISPLATIN + FLUOROURACIL | 100609012 |
| 10372725 | 10040255 | 1.86 | 63 | null | 2018-03-16 | 2018-03-16 | CARBOPLATIN + VINORELBINE | N | null | CARBOPLATIN + VINORELBINE | 100559293 |
| 10372768 | 10040256 | 1.81 | 74.4 | Palliative (P) | 2018-02-13 | 2018-03-05 | Cyclophosphamide + Docetaxel | null | N | CVP R | 101315656 |
| 10372769 | 10040257 | 1.8 | 89 | null | 2019-06-14 | 2019-06-28 | Sunitinib | 02 | null | CYTARABINE | 100043126 |
| 10372860 | 10040260 | 1.66 | 90 | 03 | null | 2019-11-11 | IPILIMUMAB + NIVOLUMAB | null | N | IPILIMUMAB + NIVOLUMAB | 101147460 |
| 10373030 | 10040261 | 1.66 | 74.4 | null | 2016-04-18 | 2016-04-26 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 100237378 |
| 10373066 | 10040262 | 1.75 | 79 | Palliative (P) | 2019-12-13 | 2019-12-22 | Venetoclax | 02 | N | CISPLATIN + FLUOROURACIL | 100977109 |
| 10373084 | 10040264 | 1.64 | null | Palliative (P) | 2018-03-04 | 2018-03-05 | R GCVP | 02 | N | VENETOCLAX | 100931040 |
| 10373186 | 10040265 | 1.59 | 101.7 | Neo-adjuvant (N) | 2019-11-13 | 2019-11-22 | CHOP R - 21 days | N | N | CHOP R | 101270990 |
| 10373271 | 10040266 | 1.65 | 68.7 | Curative (C) | 2020-07-18 | 2020-07-19 | CYCLOPHOSPHAMIDE + RITUXIMAB | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100265967 |
| 10373282 | 10040267 | 1.53 | 55 | null | null | 2018-05-23 | NIVOLUMAB | N | null | NIVOLUMAB | 101632680 |
| 10373320 | 10040268 | 1.53 | 59.9 | null | 2020-02-24 | 2020-02-27 | Folfirinox | N | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100914766 |
| 10373347 | 10040271 | 1.55 | 47.6 | Curative (C) | 2020-09-18 | 2020-09-26 | Avelumab | 02 | N | AVELUMAB | 101222893 |
| 10373383 | 10040272 | null | 82.5 | Palliative (P) | 2019-01-02 | 2019-01-07 | CTD Attenuated (Thalidomide 100mg) | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101005909 |
| 10373472 | 10040274 | 0 | 0 | Palliative (P) | 2019-06-26 | 2019-07-07 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | Y | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100289951 |
| 10373503 | 10040275 | 1.8 | 68 | null | null | 2019-08-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100235713 |
| 10373551 | 10040276 | 1.73 | 59.9 | 03 | null | 2018-11-21 | Bortezomib (weekly) | N | N | BORTEZOMIB | 100660407 |
| 10373649 | 10040278 | 1.64 | 93 | Palliative (P) | 2016-10-31 | 2016-11-03 | TEMOZOLOMIDE | 02 | N | TEMOZOLOMIDE | 101414258 |
| 10373775 | 10040280 | null | null | null | 2017-11-11 | 2017-11-13 | Irinotecan + Modified De Gramont | 99 | null | FLUOROURACIL + IRINOTECAN | 100027028 |
| 10373799 | 10040281 | 1.78 | 52.1 | Palliative (P) | 2020-05-29 | 2020-06-02 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100091287 |
| 10373856 | 10040282 | 1.74 | 70.8 | Adjuvant (A) | 2019-02-16 | 2019-02-24 | POMALIDOMIDE | 02 | N | CVP R | 100381016 |
| 10373858 | 10040283 | 1.65 | 130 | Palliative (P) | null | 2017-10-31 | CISPLATIN + FLUOROURACIL | 02 | N | POMALIDOMIDE | 101551543 |
| 10373859 | 10040284 | 1.86 | 57.15 | null | 2022-01-05 | 2022-01-05 | R Chlorambucil | N | null | CHLORAMBUCIL + RITUXIMAB | 101273141 |
| 10373865 | 10040285 | 1.71 | 100.2 | Palliative (P) | null | 2019-06-08 | CHOP R | 02 | N | CHOP R | 101464374 |
| 10373878 | 10040286 | 1.53 | null | Palliative (P) | 2021-04-06 | 2021-04-08 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101081579 |
| 10373928 | 10040288 | 1.56 | 82.8 | 03 | 2020-05-19 | 2020-05-19 | BCG Intravesical | 02 | null | VENETOCLAX | 100786051 |
| 10373964 | 10040289 | 1.63 | 45.6 | Adjuvant (A) | null | 2019-05-04 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101467626 |
| 10373971 | 10040290 | null | 75.9 | Curative (C) | 2019-09-11 | 2019-09-21 | DARATUMUMAB | null | null | CISPLATIN + FLUOROURACIL | 100013833 |
| 10374058 | 10040291 | 1.6 | 102 | Palliative (P) | 2019-06-24 | 2019-06-24 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101097009 |
| 10374079 | 10040292 | 1.73 | 101.3 | Palliative (P) | 2017-03-25 | 2017-05-14 | Pazopanib | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101179024 |
| 10374157 | 10040294 | 1.65 | 78.45 | Adjuvant (A) | 2018-11-16 | 2018-12-31 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100048198 |
| 10374161 | 10040295 | 1.59 | 0 | 03 | 2018-09-09 | 2018-09-09 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100822453 |
| 10374219 | 10040298 | 1.75 | 68.9 | null | 2022-03-29 | 2022-05-04 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101061790 |
| 10374243 | 10040299 | 1.78 | 70.75 | Palliative (P) | 2019-09-24 | 2019-09-26 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100520147 |
| 10374251 | 10040300 | 1.76 | 78.3 | 03 | 2016-11-13 | 2016-11-13 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101846402 |
| 10374452 | 10040303 | 0 | 0 | Palliative (P) | 2018-12-13 | 2018-12-22 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100599008 |
| 10374472 | 10040305 | 1.62 | 59.35 | Palliative (P) | 2018-09-24 | 2018-09-27 | CTD | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101443340 |
| 10374552 | 10040306 | 1.65 | 54.6 | Neo-adjuvant (N) | 2019-12-29 | 2020-01-08 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100742557 |
| 10374553 | 10040307 | 1.84 | 58.5 | Palliative (P) | 2018-03-03 | 2018-03-17 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 01 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101740441 |
| 10374578 | 10040308 | 1.73 | 68.2 | 03 | 2019-03-01 | 2019-03-21 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101131470 |
| 10374646 | 10040309 | null | 0 | Disease modification (D) | 2019-01-23 | 2019-02-05 | POMALIDOMIDE | 02 | null | MITOMYCIN | 101593594 |
| 10374662 | 10040310 | 1.55 | 93.8 | Palliative (P) | 2019-10-22 | 2019-10-29 | POMALIDOMIDE | N | N | CYTARABINE | 101457323 |
| 10374707 | 10040311 | 1.83 | 88.2 | Palliative (P) | 2020-04-22 | 2020-04-30 | null | 02 | null | CAPECITABINE + GEMCITABINE | 101668789 |